Breaking News Instant updates and real-time market news.

HES

Hess Corp.

$43.49

-1.8 (-3.97%)

, CEO

CNOOC

$109.48

-0.82 (-0.74%)

08:18
06/16/17
06/16
08:18
06/16/17
08:18

Hess takes final investment decision for Liza Phase 1 development

Hess (HES) announced it has sanctioned the first phase of development of the Liza Field, one of the industry's largest oil discoveries of the past decade, located on the Stabroek Block offshore Guyana. In addition, the company announced positive results from the Liza-4 well, which encountered more than 197 feet of high-quality, oil-bearing sandstone reservoirs and will underpin a potential Liza Phase 2 development. Gross discovered recoverable resources for the Stabroek Block are now estimated to be 2.0 billion to 2.5 billion barrels of oil equivalent, including Liza and other successful exploration wells on Liza Deep, Payara and Snoek. The first phase of a planned multiphase development of the Liza Field is expected to have a gross capital cost of approximately $3.2B for drilling and subsea infrastructure and will develop approximately 450 million barrels of oil, with first oil expected by 2020. The first phase of development will utilize a leased floating production, storage and offloading vessel that will have the capacity to process up to 120,000 barrels of oil per day from four subsea drill centers consisting of 17 wells, including eight producers, six water injectors and three gas injectors. Hess' net share of development costs is forecast to be approximately $955M, of which $110M is already included in Hess' 2017 capital and exploratory budget. Of the remaining net development costs, approximately $250M is expected in 2018 and approximately $330M in 2019, with the balance expected between 2020 and 2021. In 2017 and 2018, Hess and its partners plan to continue exploration and appraisal of the 6.6 million acre Stabroek block. There are numerous prospects across multiple play types on the block, representing additional multibillion barrel unrisked exploration potential. Drilling of the Payara-2 well, which will also test a deeper prospect underlying the Payara oil discovery, is expected to commence in late June following completion of a drillstem test at Liza-4. Esso Exploration and Production Guyana Limited is operator and holds 45% interest in the Stabroek Block. Hess Guyana Exploration Limited holds a 30% interest and CNOOC Nexen Petroleum Guyana Limited (CEO) holds a 25% interest.

HES

Hess Corp.

$43.49

-1.8 (-3.97%)

CEO

CNOOC

$109.48

-0.82 (-0.74%)

HES Hess Corp.
$43.49

-1.8 (-3.97%)

05/05/17
05/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Zynga (ZNGA) upgraded to Neutral from Underperform at BofA/Merrill with analyst Justin Post citing stronger engagement that is driving bookings growth. 2. Hess Corp. (HES) upgraded to Outperform from Market Perform at Wells Fargo citing what it sees as Hess' "growth potential, strong operating cost performance, balance sheet strength, exploration upside and current discounted valuation." Wells expects the company to grow at a compound annual rate of 4.9% through 2019. 3. CF Industries (CF) upgraded to Buy from Neutral at UBS with analyst John Roberts saying the stock is a top pick on the eventual agricultural recovery. Limited nitrogen capacity coming post 2017 and the dividend yield position the stock for upside, Roberts tells investors in a research note. The analyst keeps a $33 price target for the shares. 4. TreeHouse (THS) upgraded to Overweight from Equal Weight at Stephens. 5. Scripps Networks (SNI) upgraded to Overweight from Neutral at JPMorgan with analyst Alexia Quadrani citing the 10% pullback in the shares over the past month. The analyst notes Scripps offered "strong commentary" on ad revenue and is now included in Hulu Live. She keeps an $83 price target for the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/17
BOFA
05/22/17
NO CHANGE
Target $80
BOFA
Buy
Hess Corp. remains a top pick in E&P at BofA/Merrill
Bofa/Merrill analyst Doug Leggate said Hess Corp risk/reward looks attractive as shares are "discounting" below strip prices, but his base case assumes a gradual recovery above $60 by the end of the decade. The analyst said Hess remains a top idea and reiterated his Buy rating and $80 price target.
05/30/17
GSCO
05/30/17
DOWNGRADE
Target $58
GSCO
Neutral
Hess Corp. downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Brian Singer downgraded Hess Corp. to Neutral from Buy on valuation and cut its price target to $58 from $69 saying he prefers higher quality E&Ps that can deliver differentiated growth and returns in a long-term lower oil environment.
05/30/17
05/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ambarella (AMBA) downgraded to Sector Weight from Overweight at Pacific Crest with analyst Brad Erickson citing concern the company's largest customer DJI may have dual-sourced. After speaking with DJI customer service, Erickson believes Ambarella may not be the video processing provider for Spark, the $499 drone launched last week by DJI. 2. Buffalo Wild Wings (BWLD) downgraded to Underperform from Neutral at Wedbush with analyst Nick Setyan saying the upcoming proxy vote is irrelevant as neither management's strategy nor Marcato Capital's plan offer a viable solution to the company's ongoing deterioration in fundamentals. 3. Valero (VLO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Benny Wong citing refining headwinds and high exposure to RIN prices. 4. AutoZone (AZO) and O'Reilly Automotive (ORLY) were downgraded to Neutral from Outperform at Wedbush. 5. Whiting Petroleum (WLL) was downgraded to Sell from Neutral at Goldman Sachs, while Cimarex Energy (XEC) and Hess Corp. (HES) were downgraded to Neutral from Buy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CEO CNOOC
$109.48

-0.82 (-0.74%)

03/23/17
MACQ
03/23/17
UPGRADE
MACQ
Outperform
CNOOC upgraded to Outperform from Neutral at Macquarie
03/23/17
JPMS
03/23/17
UPGRADE
JPMS
Neutral
CNOOC upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Scott Darling upgraded CNOOC to Neutral following management's positive outlook for the business and recent share underperformance.
03/24/17
HSBC
03/24/17
UPGRADE
HSBC
Hold
CNOOC upgraded to Hold from Reduce at HSBC
06/05/17
HSBC
06/05/17
UPGRADE
HSBC
Buy
CNOOC upgraded to Buy from Hold at HSBC

TODAY'S FREE FLY STORIES

LEN

Lennar

$68.78

-0.48 (-0.69%)

07:44
01/17/18
01/17
07:44
01/17/18
07:44
Recommendations
Lennar analyst commentary  »

Lennar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHYDY

Norsk Hydro

$7.60

-0.16 (-2.06%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Downgrade
Norsk Hydro rating change  »

Norsk Hydro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAST

Fastenal

$55.44

-0.15 (-0.27%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Earnings
Fastenal reports Q4 EPS 45c ex-tax benefit, consensus 45c »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

LBTYA

Liberty Global

$36.56

-0.31 (-0.84%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Upgrade
Liberty Global rating change  »

Liberty Global upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Recommendations
Juno Therapeutics, Celgene analyst commentary  »

Juno Therapeutics price…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

GS

Goldman Sachs

$258.46

1.43 (0.56%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Hot Stocks
Goldman CEO: Global economy poised to accelerate, tax reform providing tailwinds »

"Last year, we…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

ONTX

Onconova

$1.74

-0.0901 (-4.92%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Hot Stocks
Onconova increases sample size in Phase 3 INSPIRE pivotal trial in MDS »

Onconova is moving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HALO

Halozyme

$19.74

-0.62 (-3.05%)

07:41
01/17/18
01/17
07:41
01/17/18
07:41
Technical Analysis
Technical Take: Halozyme drops in pre-market »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

07:41
01/17/18
01/17
07:41
01/17/18
07:41
Conference/Events
UBS oil services analyst holds an analyst/industry conference call »

Oil Services Analyst Wong…

GS

Goldman Sachs

$258.46

1.43 (0.56%)

07:41
01/17/18
01/17
07:41
01/17/18
07:41
Hot Stocks
Goldman Sachs reports Basel III CET1 ratio of 10.9% at December 31 »

The firm's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

C

Citi

$77.11

0.27 (0.35%)

07:40
01/17/18
01/17
07:40
01/17/18
07:40
Recommendations
Citi analyst commentary  »

Citi price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 24

    Jan

GS

Goldman Sachs

$258.46

1.43 (0.56%)

07:38
01/17/18
01/17
07:38
01/17/18
07:38
Hot Stocks
Goldman Sachs reports Q4 net revenue in FICC sales & trading $1B »

Net revenues in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

SIG

Signet Jewelers

$56.79

-0.15 (-0.26%)

07:38
01/17/18
01/17
07:38
01/17/18
07:38
Periodicals
U.S. judge excludes 70,000 women from Sterling Jewelers lawsuit, Reuters says »

A U.S. judge has excluded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

GS

Goldman Sachs

$258.46

1.43 (0.56%)

07:37
01/17/18
01/17
07:37
01/17/18
07:37
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman Sachs says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

GG

Goldcorp

$15.39

1.04 (7.25%)

07:37
01/17/18
01/17
07:37
01/17/18
07:37
Downgrade
Goldcorp rating change  »

Goldcorp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

GS

Goldman Sachs

$258.46

1.43 (0.56%)

07:36
01/17/18
01/17
07:36
01/17/18
07:36
Earnings
Goldman Sachs reports Q4 EPS $5.68 ex Tax Legislation, consensus $4.92 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

UNH

UnitedHealth

$232.90

4.26 (1.86%)

07:36
01/17/18
01/17
07:36
01/17/18
07:36
Recommendations
UnitedHealth analyst commentary  »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGHT

8x8, Inc.

$15.30

0.05 (0.33%)

, RNG

RingCentral

$50.65

-1.7 (-3.25%)

07:36
01/17/18
01/17
07:36
01/17/18
07:36
Upgrade
8x8, Inc., RingCentral rating change  »

8x8, Inc. upgraded to…

EGHT

8x8, Inc.

$15.30

0.05 (0.33%)

RNG

RingCentral

$50.65

-1.7 (-3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 25

    Jan

ORCL

Oracle

$49.59

0.08 (0.16%)

, PBR

Petrobras

$11.70

0.23 (2.01%)

07:35
01/17/18
01/17
07:35
01/17/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

ORCL

Oracle

$49.59

0.08 (0.16%)

PBR

Petrobras

$11.70

0.23 (2.01%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

KMI

Kinder Morgan

$19.39

-0.13 (-0.67%)

KODK

Kodak

$8.50

-0.7 (-7.61%)

MGM

MGM Resorts

$36.03

1 (2.85%)

PX

Praxair

$162.10

-2.05 (-1.25%)

PVG

Pretium Resources

$11.65

0.5 (4.48%)

PAAS

Pan American Silver

$17.24

0.58 (3.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 21

    Feb

  • 25

    Mar

07:35
01/17/18
01/17
07:35
01/17/18
07:35
General news
U.S. MBA mortgage market index rose 4.1% »

U.S. MBA mortgage market…

07:33
01/17/18
01/17
07:33
01/17/18
07:33
Conference/Events
Federal Reserve Bank of Cleveland President speaks on monetary policy »

Cleveland Federal Reserve…

SBBP

Strongbridge Biopharma

$8.35

0.35 (4.38%)

, AEZS

Aeterna Zentaris

$2.07

-0.0999 (-4.60%)

07:33
01/17/18
01/17
07:33
01/17/18
07:33
Conference/Events
Strongbridge Biopharma to host conference call »

Conference call to…

SBBP

Strongbridge Biopharma

$8.35

0.35 (4.38%)

AEZS

Aeterna Zentaris

$2.07

-0.0999 (-4.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

XRAY

Dentsply Sirona

$65.65

-0.14 (-0.21%)

07:32
01/17/18
01/17
07:32
01/17/18
07:32
Hot Stocks
Dentsply Sirona appoints Donald Casey Jr. as CEO »

Dentsply Sirona announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:31
01/17/18
01/17
07:31
01/17/18
07:31
Conference/Events
Federal Reserve Bank of Dallas President participates in a discussion »

Dallas Federal Reserve…

LCII

LCI Industries

$123.65

-2.75 (-2.18%)

07:31
01/17/18
01/17
07:31
01/17/18
07:31
Hot Stocks
LCI Industries to acquire Taylor Made Group, terms not disclosed »

LCI Industries announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.